Marina Komaroff, DrPH

  • 2Articles
  • 13.9KReads1
  • 2020–2022Active
  • 10Collaborators
  • 26Citations2

About

Marina Komaroff, DrPH, is affiliated with Research and Development at Noven Pharmaceuticals, Inc. in Jersey City, New Jersey. Komaroff has published research focused on schizophrenia and schizoaffective disorders, specifically investigating the efficacy and safety of HP-3070, an asenapine transdermal system, in clinical trials. The work includes analyses of symptom management in adults with schizophrenia. Collaborators frequently include Leslie Citrome, Takaaki Terahara, and Alexandra S. Park.

Publications

JCP
Transdermal HP-3070 for Hostility in Schizophrenia
JCP

1 Read counts for articles published before 2020 may include some non-human traffic.

2 Citation counts provided by Crossref.

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.